Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1961 2
1962 3
1965 2
1966 1
1973 1
1980 2
1981 4
1982 4
1983 1
1984 3
1986 1
1987 1
1988 2
1989 2
1991 4
1992 6
1993 4
1994 5
1995 3
1996 1
1997 1
1998 3
1999 1
2000 2
2001 3
2002 2
2003 4
2004 5
2005 1
2006 3
2007 9
2008 8
2009 6
2010 7
2011 13
2012 12
2013 16
2014 18
2015 10
2016 12
2017 11
2018 19
2019 14
2020 13
2021 8
2022 9
2023 8
2024 8
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM. Roboz GJ, et al. Among authors: hickman d. Blood. 2020 Feb 13;135(7):463-471. doi: 10.1182/blood.2019002140. Blood. 2020. PMID: 31841594 Free PMC article. Clinical Trial.
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.
Livingston JA, Blay JY, Trent J, Valverde C, Agulnik M, Gounder M, Le Cesne A, McKean M, Wagner MJ, Stacchiotti S, Agresta S, Quintás-Cardama A, Reilly SA, Healy K, Hickman D, Zhao T, Ballesteros-Perez A, Khalil A, Collins MP, Piel J, Horrigan K, Lefkovith A, Innis S, Lazar AJ, Cote GM, Wagner AJ. Livingston JA, et al. Among authors: hickman d. Clin Cancer Res. 2025 Feb 17;31(4):628-638. doi: 10.1158/1078-0432.CCR-24-2583. Clin Cancer Res. 2025. PMID: 39660994 Clinical Trial.
Review of Rodent Euthanasia Methods.
Shomer NH, Allen-Worthington KH, Hickman DL, Jonnalagadda M, Newsome JT, Slate AR, Valentine H, Williams AM, Wilkinson M. Shomer NH, et al. Among authors: hickman dl. J Am Assoc Lab Anim Sci. 2020 May 1;59(3):242-253. doi: 10.30802/AALAS-JAALAS-19-000084. Epub 2020 Mar 5. J Am Assoc Lab Anim Sci. 2020. PMID: 32138808 Free PMC article. Review.
Small Animal Enclosures and Housing.
Hickman DL, Hickman-Davis JM, Peveler J, Swan M. Hickman DL, et al. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 21. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 21. PMID: 29787225 Free Books & Documents. Review.
Arylamine N-acetyltransferase.
Sim E, Hickman D, Coroneos E, Kelly SL. Sim E, et al. Among authors: hickman d. Biochem Soc Trans. 1992 May;20(2):304-9. doi: 10.1042/bst0200304. Biochem Soc Trans. 1992. PMID: 1397616 Review. No abstract available.
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study.
Garcia-Manero G, Goldberg AD, Winer ES, Altman JK, Fathi AT, Odenike O, Roboz GJ, Sweet K, Miller C, Wennborg A, Hickman DK, Kanagal-Shamanna R, Kantarjian H, Lancet J, Komrokji R, Attar EC, Sallman DA. Garcia-Manero G, et al. Among authors: hickman dk. Lancet Haematol. 2023 Apr;10(4):e272-e283. doi: 10.1016/S2352-3026(22)00403-3. Lancet Haematol. 2023. PMID: 36990622 Clinical Trial.
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.
DiNardo CD, Fathi AT, Kishtagari A, Bhalla KN, Quintás-Cardama A, Reilly SA, Almon C, Patriquin C, Nabhan S, Healy K, Hickman D, Collins MP, Khalil A, Corrigan D, Zhao T, Piel J, Lyons K, Horrigan K, Schuck V, Martin P, Elliott G, Lahr DL, Bosinger M, D'Aco K, Smolen GA, Hentemann M, Loghavi S, Agresta S, Savona MR, Stein EM. DiNardo CD, et al. Among authors: hickman d. Clin Cancer Res. 2025 Jun 13;31(12):2327-2338. doi: 10.1158/1078-0432.CCR-24-3790. Clin Cancer Res. 2025. PMID: 40238563 Clinical Trial.
The impedance pneumography.
GEDDES LA, HOFF HE, HICKMAN DM, MOORE AG. GEDDES LA, et al. Among authors: hickman dm. Aerosp Med. 1962 Jan;33:28-33. Aerosp Med. 1962. PMID: 13897457 No abstract available.
273 results